Late-Breaking Science | Scientific Sessions

AHA speaker dais

Uncovering novel approaches in heart failure science

Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock

22 Aha Zb0087 Web

Trials’ results compare loop and thiazide diuretics and highlight ineffectiveness of novel fibrate therapy for reducing CV risk

Discussants at Scientific Sessions

Late-Breaking Science announced

Manesh R. Patel, MD, Chair of the Committee of the Scientific Sessions Program

Plan your schedule now for Late-Breaking Science

audience

Early ablation bests medication in treatment naïve AFib patients

audience shot

First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension

Data-driven precision medicine

Data-driven precision medicine

Finding and helping patients with undiagnosed or undertreated cardiovascular diseases

audience shot

Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD

LBS 05 panelists

Trials’ results highlight supplement ineffectiveness and potential for novel therapies to lower lipoprotein(a), reduce CKD progression

audience shot

Bivalirudin superior to unfractionated heparin in primary PCI following STEMI

Panelists of the Mindful Disruption panel

Overcoming health disparities, health care advocates and mindfulness can better manage BP and CVD

Person putting on tennis shows

Join the Wellness Challenge at #AHA22

Download the Wellness App and use your fitness devices to compete with other attendees.

Scientific Sessions attendees in lobby

Join us for Scientific Sessions 2022 in Chicago or online

Welcome back to the full experience of the world’s foremost celebration of cardiovascular and brain health science!

Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD

Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption

Lbs02 Group Blood Patel

Update on local and global hypertension science

Late-breaking science uncovers findings about hypertension.

(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA

Late-Breaking Science: New information in cardiac disease

(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA

The latest science in heart failure

(From left to right): Danielle Belardo, MD, Rafael Diaz, MD, and Christie Mitchell Ballantyne, MD, FAHA

Trials’ results highlight the potential for fish oil to fight COVID-19 and MK-0616 to lower cholesterol

(left to right): Jacqueline E. Tamis-Holland, MD, and Jane Armitage, FRCP, FFPH, OBE

New drugs, indications in cardiovascular disease

Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD

Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption

Newsletter Card Late Breaking

Monday's Late-Breaking Science presentations

Maxresdefault 6190740f4299a

#AHA21 highlights for Day 1

Marko Banovic, MD, PhD

Valves, veins and new viewpoints in cardiothoracic surgery

Newsletter Card Late Breaking

Sunday's Late-Breaking Science presentations

Marko Banovic, MD, PhD

Valves, veins and new viewpoints in cardiothoracic surgery

Newsletter Card Late Breaking

Sunday's Late-Breaking Science presentations